SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 76 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $2,534,000 | +233.4% | 354,861 | +204.5% | 0.39% | +246.4% |
| Q2 2014 | $760,000 | -39.1% | 116,556 | -38.3% | 0.11% | -38.5% |
| Q1 2014 | $1,248,000 | +37.3% | 188,803 | -1.5% | 0.18% | +41.1% |
| Q4 2013 | $909,000 | +330.8% | 191,691 | +350.4% | 0.13% | +303.1% |
| Q3 2013 | $211,000 | – | 42,557 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |